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Background and Purpose To test whether alcohol intake, both observational and estimated by 
genetic instruments, is associated with risk of ischemic and haemorrhagic stroke.
Methods We used data from the Copenhagen City Heart Study 1991 to 1994 and 2001 to 2003, 
and the Copenhagen General Population Study 2003 to 2012 (n=78,546). As measure of alcohol 
exposure, self-reported consumption and genetic variation in alcohol metabolizing genes (alcohol 
dehydrogenase ADH1B and ADH1C) as instrumental variables were used. Stroke diagnoses were 
obtained from a validated hospital register. 
Results During follow-up 2,535 cases of ischemic and haemorrhagic stroke occurred. Low and 
moderate alcohol intake (1 to 20 drinks/week) was associated with reduced risk of stroke. The hazard 
ratios associated with drinking 1 to 6, 7 to 13, and 14 to 20 drinks/week were 0.84 (95% confidence 
interval [CI], 0.76 to 0.92), 0.83 (95% CI, 0.73 to 0.94), and 0.84 (95% CI, 0.73 to 0.97), respectively, 
compared with drinking <1 drink/day. ADH1B and ADH1C genotypes were not associated with risk of 
stroke. Further analysis to test the included measures revealed that  increasing alcohol intake (per 1 
drink/day) was positively associated with risk of alcoholic liver cirrhosis, but not associated with risk of 
stroke, and that increasing blood pressure (per systolic 10 mm Hg) was not associated with risk of 
alcoholic liver cirrhosis, but positively associated with risk of stroke. 
Conclusions Low and moderate self-reported alcohol intake was associated with reduced risk of 
stroke. The result was not supported by the result from the causal genetic analysis. 
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Introduction
 
Alcohol is consumed widely throughout the world. In Western 
countries, abstainers constitute the minority while most have a 
light to moderate alcohol intake (drinking a max of 2 and 3 
drinks per day for women and men). Harms associated with 
this habit are therefore of huge public health and of potential 
clinical concern. 
The association between alcohol intake and stroke risk has 
been addressed in a number of epidemiological studies, with 
differing results; especially controversy exists whether drinking 
in moderation confers a reduced risk of ischemic stroke, in ac-
cordance with some studies,1-5 and increased risk of haemor-
rhagic stroke.1,6 Moderate alcohol intake was not associated 
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with stroke, ischemic or haemorrhagic, in most studies3,7-11 
which however in a recent meta-analysis was summed up to a 
significantly reduced pooled relative risk (RR) of ischemic 
stroke for a low intake (<15 g equalling approximately 1.3 
drinks per day) compared with abstaining.12 However, especially 
the largest individual studies that took part of the meta-analy-
sis contributed with insignificant findings with statistical esti-
mates near 1.0, while studies of smaller size had results further 
away from the null, all in all indicating that a “protective ef-
fect” of alcohol on ischemic stroke is either small or that bias is 
present. Another meta-analysis also concluded that light to 
moderate drinking (≤2 drinks/per day) was associated with a 
reduced risk of ischemic stroke and heavy drinking (>4 drinks/
per day) was associated with increased risk of both ischemic 
and haemorrhagic stroke.13
Generally, when studying health effects associated with 
drinking in moderation, one has to rely on the participants’ 
own report, implying possibility of reverse causality and con-
founding. Disentangling causal effects of alcohol from effects 
of related life style factors is likely to be especially difficult at 
the low to moderate intake level, as difference in true risk is 
small compared with the reference group of non-drinkers. 
Complicating such comparison further is the facts that non-
drinkers often constitute a heterogeneous group of individuals 
who abstain by simple preference and individuals who abstain 
due to health or socioeconomic reasons. For instance, relatively 
more abstainers than light drinkers have chronical diseases and 
low socioeconomic position.14,15
An attempt to address the problems associated with self-re-
ported information is to use the Mendelian randomization de-
sign, a method that uses genetic variants as instrumental vari-
ables for the exposure, instead of the exposure itself.16,17 For 
alcohol, functional variants in genes encoding alcohol dehy-
drogenase (ADH), responsible for the majority of the body’s al-
cohol degradation, are associated with extent of alcohol in-
take: individuals who have the fast alcohol degrading alleles 
ADH1B*2 and ADH1C*1 consume less alcohol than those with 
slow degrading alleles ADH1B*1 and ADH1C*2, which persists 
across age groups from early adulthood to old age, and ob-
served in various populations.18-22 In general, instruments valid 
for Mendelian randomisation (MR) analysis should be associat-
ed with the exposure of interest (in this case, amount of alco-
hol intake) and should influence the outcome through that ex-
posure only;23 i.e., there should be no pleiotropic effects. For 
the alcohol dehydrogenase 1B and 1C (ADH1B and ADH1C) 
genotypes, no pleiotropic effects have been identified.24 All 
taken together, ADH genotypes are valid candidates for unbi-
ased instruments of lifelong alcohol consumption.
In this study we tested the hypothesis that alcohol intake is 
associated observationally and causally through genetic varia-
tion with risk of any, ischemic and haemorrhagic stroke. For 
this purpose, we used data from two large population-based 
cohorts with information on self-reported alcohol consumption 
and genetic variations in ADH1B and ADH1C as instrumental 
variables. 
Methods
Study populations
The Copenhagen General Population Study (CGPS) is an ongo-
ing prospective study of the Danish general population initiat-
ed in 2003. To be eligible, participants had to be of Danish de-
scent (i.e., the participant and both parents were born in Den-
mark and were Danish citizens). Among individuals living in 
counties of greater Copenhagen aged 20 to 40 years, 25% 
were invited, whereas all eligible people aged >40 years were 
invited. The response rate was 42%. When the present study 
was initiated, 84,720 individuals had been included.
The Copenhagen City Heart Study (CCHS) was initiated in 
1976 where a random sample of the Danish general population 
above age 20 years living in the Center of Copenhagen was in-
vited to participate (number of participants, 14,223; response 
rate, 74%). This examination was followed by three examina-
tions; a second examination in 1981 to 1983, where all previ-
ously invited plus 500 new individuals aged 20 to 24 years 
were invited (n=12,698, 70%); a third examination in 1991 to 
1994 where all previously invited plus 3,000 new individuals 
aged 20 to 49 years were invited (n=10,135, 61%); and a 
fourth examination in 2001 to 2003 where all previously invit-
ed plus an additional sample of 1,040 individuals aged 20 to 
29 years were invited (n=6,238, 50%). Eligibility criterion was 
Danish citizenship, and the participants does not reflect the 
ethnic admixture of Copenhagen (for instance, the proportion 
of inhabitants with foreign citizenship was 8% in 1994). How-
ever, even a few participants of foreign ethnicity could con-
found our results since the ADH1B*2 allele has shown consid-
erable population stratification.25 Hence, information on birth 
place as recorded in the Danish Civil Registration System26 was 
obtained, and participants who were born in Asia, Africa, the 
Middle East, South America, and Greenland were excluded 
(n=243).
We used data from CCHS 1991 to 1994 and 2001 to 2003 
examinations (n=11,365) and the CGPS 2003 to 2012 exami-
nation (n=84,720).27-29 Data were collected following similar 
principles. Participants filled in a questionnaire that was re-
viewed by an investigator on the day of attendance, had a 
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physical examination performed, and had blood samples drawn 
for biochemical measurements and DNA extraction. Written 
informed consent was obtained. The Danish Ethics Committee 
approved the studies (No. 100.2039/91 and H-01-144/01).
Assessment of alcohol consumption
Participants reported their consumption of beer (in bottles), 
wine (in glasses), and spirits (in units) with response categories 
of “never/ hardly ever,” “monthly,” “weekly,” or “daily” and 
number of drinks per week. The total number of drinks per 
week was calculated by summing up the individual types of al-
cohol and was categorised as in previous studies:30 1 to 6, 7 to 
13, 14 to 20, 21 to 27, 28 to 34, and ≥35 drinks per week with 
1 drink equalling 12 g alcohol. For women, the highest catego-
ry was ≥28 drinks per week. 
Previously, we have shown that stepwise increments of the 
self-reported alcohol consumption consistently corresponded 
to stepwise increments in factors expected to correlate with 
amount of alcohol consumption (alanine aminotransferase, 
γ-glutamyl transpeptidase, erythrocyte volume, and alkaline 
phosphatase), speaking in favour of the validity of self-reported 
alcohol consumption.18 
ADH1B and ADH1C genotypes
DNA was isolated from full blood and stored at –45°C. Partici-
pants were genotyped for the ADH1B genotype (rs1229984; Ar-
g47His) and ADH1C genotype (rs698; Ile349Val) by Nanogen 
Technology (Carson City, NV, USA)31,32 and TaqMan assays (Applied 
Biosystems, Foster City, CA, USA).19 Genotypes were in Hardy-
Weinberg equilibrium in both studies (P>0.05). Genotypes AD-
H1B*2/1 and ADH1B*2/2 were grouped because of few partici-
pants with these genotype. ADH1B and ADH1C genotypes were 
combined and ranked according to expected enzyme activity, 
ranging from most to least active (1, ADH1B*2/x+ADH1C*1/1; 2, 
ADH1B*1/1+ADH1C*1/1; 3, ADH1B*1/1+ADH1C*1/2; 4, 
ADH1B*1/1+ADH1C*2/2). Additionally, we used regression analy-
sis with alcohol intake as a dependent variable and sex and geno-
types as independent variables to test how much of the variance 
in alcohol consumption was explained by the ADH1B and ADH1C 
genotypes.
Assessment of ischemic and haemorrhagic stroke
Information on diagnosis of stroke was obtained from the Dan-
ish National Patient Register that holds records of all Danish 
hospital admissions since 1978 and further outpatient and 
emergency ward contacts since 1995, and from the Danish 
Causes of Death Registry which contains information on causes 
of death for all deceased in Denmark.33-35 In both registers, re-
cords are classified according to World Health Organization 
(WHO) International Classification of Diseases (ICD). Records 
with the following codes implying stroke were extracted: ICD-
8 431 to 438 and ICD-10 I60 to I68 and G45. 
All diagnoses of stroke were validated individually. Records 
were requested from general practitioners and hospitals and 
validated by two experienced medical doctors independently, 
blinded to the test results.36,37 Ischemic stroke was defined ac-
cording to WHO criteria as rapidly developing signs of focal or 
global disturbance of cerebral function lasting >24 hours (un-
less interrupted by death), with no apparent nonvascular 
cause.38 Haemorrhagic stroke and subarachnoidal hemorrhage 
were excluded from the ischemic stroke group. To distinguish 
among infarction, intracerebral hemorrhage, and subarachnoi-
dal hemorrhage, either computed tomography or magnetic 
resonance imaging scan, spinal fluid examination, autopsy, or 
surgical description were required. If the scan did not show in-
farction or hemorrhage, but symptoms in accordance with 
stroke criteria, that event was diagnosed as ischemic stroke. 
The diagnosis of ischemic and haemorrhagic stroke was not 
applied in cases in which a scan revealed signs of prior cere-
brovascular disease, but without history of any symptoms, if 
symptoms were nonfocal, or if symptoms lasted <24 hours.39 
Alcoholic liver cirrhosis was ascertained similarly from the Dan-
ish registries using ICD-8 code 571.0 and ICD-10 code k70.3.
Statistical analysis
Of the initial sample of 89,675 individuals, we excluded those 
with stroke prior to baseline (n=2,737), missing information on 
alcohol consumption (n=4,499) and covariates (smoking 
[n=2,573]), school education (n=247), body mass index (BMI) 
(n=511), and leisure time physical activity (n=562). The final 
analytic sample therefore consisted of 78,546 men and women 
(where genotype information was available for 74,632 individ-
uals) (Table 1).
Variables considered being potential confounders included 
the following: age; school education (<8, 8 to 11, and >11 
years of education, corresponding to lower primary school, 
higher primary school, and secondary school); leisure time 
physical activity (sedentary, light, moderate, and vigorous); 
smoking (never smoker, former smoker, and current smoker of 
1 to 14, 15 to 24, and >24 g of tobacco/day); BMI (linearly); 
family history of cardiovascular disease (either biological par-
ent having had myocardial infarction or stroke); diabetes (by 
self-report), angina pectoris (by self-report), hypertension (by 
self-report); ischemic heart disease (hospital diagnosis before 
baseline, yes/no); congestive heart failure (hospital diagnosis 
before baseline, yes/no); angina pectoris (by self-report); heart 
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medication (by self-report, yes/no); and use of cholesterol-
lowering medication (by self-report, yes/no). Analyses were 
conducted using Stata version 12.1 (StataCorp, College Station, 
TX, USA). 
P-values for trend between genotypes and baseline charac-
teristics were calculated using chi-square test for categorical 
variables and Kruskal-Wallis test for continuous variables. For 
this purpose, genotypes were assigned with values reflecting 
the effect of genotypes on alcohol consumption.
Participants accrued person-time from baseline until time of 
stroke (n=2,335), death (n=7,524), emigration (n=468), or end 
of follow-up (n=68,161), whichever occurred first. Data from 
the CGPS and CCHS were combined after having ensured that 
results were similar in the two studies separately. This was 
tested formally in a nested log-likelihood test (P=0.16 for any 
stroke). Power calculation for the MR analysis were conducted 
using Stata procedure power logrank. Analyses were conducted 
following the four steps below, in accordance with the Mende-
lian randomization study principle.17,40
Self-reported alcohol intake and stroke
We tested whether alcohol intake was associated with stroke 
using Cox proportional hazards models with delayed entry. Age 
(in days) was used as the underlying time axis to ensure maxi-
mal adjustment for confounding by age. The Cox proportional 
hazards assumption was examined graphically by plots of log 
(time) by log (–log [survival probability]) and statistically by in-
troducing interaction terms between age and alcohol intake in 
the model. No violations were detected (P>0.05). 
Association between ADH1B and ADH1C genotypes and 
alcohol intake
Second, we tested whether ADH1B and ADH1C genotypes and 
their combinations were associated with alcohol intake. This 
was done in linear regression analysis, using the Cuzick’s ex-
tension of the Wilcoxon rank sum test to calculate P-value for 
trend. 
Alcohol and stroke: using ADH1B and ADH1C as instru-
ments for alcohol intake
Third, we tested whether genotype combinations were associ-
ated with risk of stroke using Cox regression, modelled as de-
scribed in 'step 1.'
Alcohol and stroke: observational versus genetic estimates
Fourth, to test a potential causal association between alcohol 
and stroke, we performed instrumental variable analysis with a 
two-stage regression model using genotype combinations as 
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instruments to estimate the effect of per additional genetic 
drink per day on risk of stroke.16 The first stage was a linear re-
gression of genotype combinations on alcohol consumption. F-
statistics >10 indicates sufficient statistical strength to carry 
out statistically valid instrumental variable analysis, which was 
confirmed (F=22.0).41 The second stage was a logistic regres-
sion of alcohol intake determined by genotype combinations 
(generated in the first stage) on stroke to calculate genetic risk 
ratios. For comparison, we calculated hazard ratios (HRs) for 
the association per additional observational drink per day and 
risk of stroke.
Applicability of included measures
To test the applicability of the included measures we tested the 
included measures on already well-established associations, 
e.g., alcohol intake and risk of alcoholic liver disease and blood 
pressure and risk of any stroke.
Results 
Baseline characteristics of the 37,344 men and 44,935 women 
are listed in Table 1, in total and by categories of alcohol in-
take. Further, P-values are shown for associations between 
each characteristic and alcohol consumption, and between 
characteristics and ADH1B and ADH1C genotype combinations. 
Most characteristics were associated with alcohol consump-
tion. In contrast, none of the baseline characteristics were as-
sociated with genotypes after Bonferroni correction for 22 
comparisons. This illustrates likely substantial confounding in 
observational analyses, but none detected in causal, genetic 
analyses. The mean follow-up duration was 7.9 years. During 
the study period, 2,535 incident cases of ischemic and haemor-
rhagic stroke occurred. 
Men and women who consumed 1 to 20 drinks/week had 
reduced risk of any stroke (ischemic and haemorrhagic stroke 
combined) compared to men and women consuming less than 
1 drink/week (Figure 1). No significant association was seen 
among individuals consuming 21 drinks/week or more. The HRs 
for any stroke associated with drinking 1 to 6, 7 to 13, and 14 
to 20 drinks/week versus less than 1 drink/week were 0.84 
(95% confidence interval [CI], 0.76 to 0.92), 0.83 (95% CI, 0.73 
to 0.94), and 0.84 (95% CI, 0.73 to 0.97), respectively, and the 
P-value for linear trend was <0.0001. The pattern was similar 
for ischemic and haemorrhagic stroke, but only statistical sig-
nificant for ischemic stroke. 
Evidence of a nonlinear relationship between alcohol intake 
and total stroke was further supported by Figure 2 showing 
HRs for any stroke by increasing alcohol intake with <1 drink/
Figure 1. Hazard ratio for any stroke, ischemic stroke, and haemorrhagic stroke according to weekly alcohol intake (observational) among men and women 
(n=78,546). CI, confidence interval. *Adjusted for sex, smoking status, amount of smoking, school education, body mass index, physical activity, angina pecto-
ris, diabetes, cardiovascular medications, and cohort; †P-value for linear trend; ‡P-value for quadratic trend.
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week as reference. Indeed, alcohol intake of 1 to 20 drinks/
week was associated with reduced risk of total stroke. Heavy 
alcohol intake tends to be associated with an increased risk of 
any stroke, indicating a j-shaped association (Figure 2); how-
ever, the association between high alcohol intake and risk of 
any stroke was not statistically significant (Figure 1). 
Further, testing for non-linear trend using the mean alcohol 
intake for each genotype combination (Table 2), and modelling 
this amount with a linear and a square term analogous to test 
for trend as presented in Figure 1 was statically insignificant 
(P=0.40 and P=0.42 for linear and squared terms). Men and 
women with the ADH1B and ADH1C slow and intermediate 
genotypes had higher alcohol consumption than those with the 
ADH1B and ADH1C fast genotype (Table 2). For example, indi-
viduals with the ADH1B and ADH1C slow and intermediate gen-
otypes on average drank 22% and 25% more alcohol than indi-
viduals with the ADH1B and ADH1C fast genotype. Result from 
the regression analysis showed that 10% of the variation in al-
cohol consumption was explained by the ADH1B and ADH1C 
genotypes.
The risk of total stroke was similar among individuals with 
genotypes coding for high compared with low alcohol con-
sumption: using the ADH1B and ADH1C genotype combination 
associated with the lowest alcohol consumption (on average 
8.9 drinks/week) as reference, the HR for any stroke for the 
genotype combination that was associated with the highest 
alcohol consumption (11.1 drinks/week) was 1.15 (95% CI, 0.66 
to 2.02) (Table 2). Results obtained in the present study were in 
keeping with results from the literature, when examining al-
ready established association. Hence, increasing alcohol con-
sumption (per 1 drink/day) was positively associated with risk 
of alcoholic liver disease (HR, 1.23; 95% CI, 1.18 to 1.27), but 
not associated with risk of any stroke (HR, 1.04; 95% CI, 0.98 
to 1.20), and increasing blood pressure (per systolic 10 mm Hg) 
was not associated with risk of alcoholic liver disease (HR, 
1.04; 95% CI, 0.98 to 1.10) but positively associated with risk 
of any stroke (HR, 1.11; 95% CI, 1.05 to 1.17) (Figure 3). 
Discussion 
In this prospective cohort study, observational (self-reported) 
alcohol consumption was associated with lower risk of any 
stroke (ischemic and haemorrhagic stroke combined) in men 
and women consuming 1 to 20 drinks/weeks. Heavy alcohol 
intake if anything tended to be associated with an increase in 
the risk of any stroke, indicating a j-shaped association. How-
ever, no significant association was seen among individuals 
consuming 21 drinks/week or more. A similar pattern was seen 
for ischemic and haemorrhagic stroke separately, but this was 
only significant for ischemic stroke with the most accumulated 
endpoints. From analyses using genetic variation in alcohol 
metabolizing genes (ADH1B and ADH1C) as instrumental vari-
ables for alcohol consumption, we found no evidence to sup-
port causality of the observational findings. When examining 
Figure 2. (A-C) Dose-response relationship between alcohol intake and 
hazard ratios of any stroke (ischemic and haemorrhagic stroke combined), 
ischemic stroke and haemorrhagic stroke. The solid curve (A) illustrates the 
hazard ratios and the dashed lines (B) illustrates the 95% confidence inter-
vals of any stroke, ischemic stroke and haemorrhagic stroke, respectively, 
by weekly alcohol intake (observational).
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already established associations for the included endpoints, the 
results obtained in the present study are in agreement with re-
sults from the literature.
Our results are in accordance with the results in a recent me-
ta-analysis of 20 prospective cohort studies showing that low 
alcohol intake (<15 g/day, corresponding to less than 1 standard 
drink), compared with no alcohol intake, was associated with a 
reduced risk of any stroke (RR, 0.85; 95% CI, 0.75 to 0.95). Fur-
ther, compared with no alcohol intake, moderate alcohol intake 
(15 to 30 g/day, corresponding to approximately 1 to 2 standard 
drink) showed no significant association with total stroke (RR, 
1.01; 95% CI, 0.93 to 1.09) whereas heavy alcohol intake was 
associated with an increased risk of any stroke.12 Low alcohol 
intake was likewise associated with a reduced risk of ischemic 
stroke. However, no association between moderate and heavy 
alcohol consumption and ischemic stroke was evident. Last, the 
meta-analysis found no association between alcohol intake at 
any level and risk of haemorrhagic stroke. Another meta-analy-
sis of 27 prospective cohort studies found that light to moder-
ate alcohol consumption (≤2 drinks/day) was associated with a 
reduced risk of ischemic stroke but not associated with haemor-
rhagic stroke subtypes.13 Further, heavy drinking (>4 drinks/day) 
was found to be associated with all stroke types.
Plausible explanations 
Our result and the dose-response meta-analysis suggest that a 
potential nonlinear relationship is present between alcohol in-
take and risk of any stroke, and that an alcohol intake of 1 to 
20 drinks/week is associated with a reduced risk of any stroke. 
Hence, the association seems to be j-shaped. The divergent 
dose–response relationships between alcohol consumption and 
risk of ischemic and haemorrhagic stroke subtypes suggest that 
different mechanisms underlie associations with the different 
stroke types. Alternatively, the slightly different results may be 
due to fewer haemorrhagic stroke events compared with isch-
emic stroke events, and thus the statistical power could be too 
low for reliable risk estimates for haemorrhagic stroke alone. 
Heavy alcohol intake may be associated with an increased risk 
of haemorrhagic events because heavy alcohol intake poten-
tially results in high blood pressure, reduced platelet aggrega-
tion, and enhanced fibrinolysis.12,13 Further, alcohol consump-
tion is associated with increased high density lipoprotein cho-
lesterol levels, decrease platelet aggregation, increase fibrino-
lysis, and decrease plasma fibrinogen levels and this might help 
explain the lower risk of ischemic stroke.12,13
Strengths and limitations 
From analysis using ADH genotypes as instrument for alcohol 
consumption, we did not obtain results that supported causali-
ty of the observational finding. The strength of using genetic 
instruments for lifestyle exposures is that confounding from 
associated risk factors and reverse causation are unlikely, and 
causal interpretation of results may be more straight forward 
than causal interpretation of observational findings.17 Further, 
selection bias due to non-participation is less likely to affect 
results for genetic instruments42 whereas as for results ob-
tained for self-reported alcohol intake, bias cannot be ruled 
out: if alcohol intake was associated with non-participation 
Figure 3. Hazard ratios and 95% confidence intervals (CIs) for any stroke, ischemic stroke, haemorrhagic stroke, and alcoholic liver disease by weekly alcohol 
intake (observational) and systolic blood pressure (SBP).
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Table 2. Hazard ratio (95% CI) for any stroke according to genotype combination in 74,632 men and women
ADH1B/ADH1C combination Relative enzyme activity No. Cases Mean (drinks/wk) Δ (%) HR* (95% CI)
1 (2/2+2/1; 1/1) Fastest 1,701 51 8.9 0 1.00
2 (1/1; 1/1) Intermediate (fast) 24,077 750 10.8 21 1.09 (0.73—1.62)
3 (1/1; 1/2) Intermediate (slow) 35,690 1,162 10.9 22 1.13 (0.69—1.86)
4 (1/1; 2/2) Slowest 13,164 429 11.1 25 1.15 (0.66—2.02)
HR, hazard ratio; CI, confidence interval.
*Adjusted for age and sex. 
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and with risk of stroke, results would be influenced.43 Hence, 
heavy drinkers who participate may be at better health than 
heavy drinkers in the underlying population, whereas light and 
moderate drinkers who volunteer may be more representative 
of moderate and non-drinkers drinkers generally. Ultimately, 
such a mechanism would lead to more accurate results among 
the light to moderate drinkers and underestimated results 
among the heavy drinkers. 
A limitation is that the ADH1B and ADH1C genotypes are 
not strong instruments, meaning that the influence on the 
amount of alcohol consumption is limited; 10% of the varia-
tion in alcohol intake was explained by the ADH1B and ADH1C 
genotypes in this population. Hence, the lack of a positive find-
ing does not preclude that alcohol is causally associated with 
stroke. Further, using these genotypes as instruments implies a 
linear model between genetic alcohol consumption and the 
risk of stroke; if the association between alcohol and risk of 
stroke for instance is indeed threshold-shaped, then the genet-
ic instrument has little power to pick it up.
Further, another limitation is lack of power in the MR analy-
sis. We computed the lowest HR that can be picked up with 
the present set-up, for the ADH1B/ADH1C combination with 
the highest alcohol intake (i.e., the 1/1;1/2 group, please refer 
to Table 2), with a 90% power and a significance level of 0.05: 
this HR is 0.65, meaning that we do not have the adequate 
power to assess a HR of 0.84. 
The reason that ADH genotypes is associated with alcohol 
consumption is most likely that—for a given level of intake—in-
dividuals with fast alcohol degradation have higher levels of 
acetaldehyde leading to unpleasant symptoms such as nausea 
and flushing compared with individuals with slow degradation, 
causing them to drink less. Thus, peak levels of acetaldehyde, 
known to be carcinogenic and playing important roles in the 
development of alcohol-related diseases,44 will be higher in 
fast compared to slow metabolisers, meaning that by using 
ADH1B and ADH1C genotypes as instruments the difference in 
amount of alcohol cannot be studied independently of differ-
ence in acetaldehyde levels, which constitute a final limitation 
of this approach.
A candidate for another instrument of alcohol intake to be 
used in future MR studies is the recently identified single nu-
cleotide polymorphism (SNP) in Klothoβ (KLB) gene (encoding 
β-Klotho), demonstrated to have a role in the regulation of al-
cohol drinking, observed in independent samples.45 While the 
mechanism linking the KLB gene with alcohol intake is still un-
known, making the potential for using it as an instrument for 
alcohol intake unsure it is a promising candidate to be used 
alone or in combination with ADH1B and ADH1C genotypes 
forming stronger instruments. Last, it was not possible to sepa-
rate former drinkers from abstainers and hence, some drinker 
misclassification might have occurred. 
Study strengths include the large number of individuals and 
stroke endpoints, and that the hospital register information on 
the stroke diagnosis was highly sensitive and specific.36,37 Fur-
ther, the National Danish Patient Register covers all hospital-
izations in Denmark including outpatients and emergency 
wards since 1995, and only if participants were treated in an-
other country or by a general practitioner solely, the informa-
tion would be lacking. Hence, loss to endpoint findings is con-
sidered to be negligible. 
Conclusions
In this pooled analysis of 78,546 individuals, self-reported al-
cohol intake of 1 to 20 drinks/week was associated with re-
duced risk of any stroke. The risk of any stroke if anything 
tended to be increased among individuals with heavy alcohol 
intake, indicating a j-shaped association. However, no signifi-
cant association was found between high alcohol consumption 
and risk of any stroke. The pattern was similar for ischemic 
stroke and haemorrhagic stroke, but only statistically signifi-
cant for ischemic stroke. Finally, we found no evidence to sup-
port a causal relation of a linear association between alcohol 
intake and total stroke from genetic estimates. However, this 
could be explained by lack of power in the MR analysis.
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